Hikma US launches generic version of Lundbeck's Onfi
10th Dec 2018 14:18
(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Lundbeck's Onfi, which is used for the treatment of seizures associated with Lennox-Gastaut syndrome (LGS) in patients of two years and older.
Read moreNew management to reinvigorate Smith & Nephew, says Morgan Stanley
10th Dec 2018 13:31
(Sharecast News) - Morgan Stanley upped its stance on Smith & Nephew to 'overweight' from 'equalweight' on Monday, lifting the target price to 1,692p from 1,457p as it argued that new management should help to reinvigorate the top line performance following years of stagnation.
Read moreJefferies downgrades NMC Health, ups Hikma
27th Nov 2018 12:46
(Sharecast News) - Jefferies has adopted a more cautious approach to blue chip NMC Health, cutting its rating to 'underperform' over a range of concerns, including corporate governance.
Read moreTuesday broker round-up
27th Nov 2018 12:26
(Sharecast News) - Pets At Home Group: Liberum downgrades to hold with a target price of 120p.
Read moreHikma in five-year licensing and supply agreement with China's Hansoh
27th Nov 2018 09:59
(Sharecast News) - Hikma Pharmaceuticals has announced a five-year licensing and supply agreement with China's Hansoh Pharmaceutical Group.
Read moreTuesday broker round-up
20th Nov 2018 14:00
(Sharecast News) - Coats: RBC Capital Markets initiates at outperform with a target price of 110p.
Read moreHikma US launches generic version of Pfizer insomnia tablets
19th Nov 2018 10:43
(Sharecast News) - Hikma Pharmaceuticals' US subsidiary has launched a generic equivalent to Pfizer's Halcion tablets for insomnia.
Read moreTuesday broker round-up
30th Oct 2018 13:15
(Sharecast News) - Inmarsat: Numis upgrades to hold with a target price of 430p.
Read morePeel Hunt upgrades Hikma, says upgrade cycle will drive shares
16th Aug 2018 14:17
(Sharecast News) - Peel Hunt upgraded Hikma Pharmaceuticals to 'add' from 'hold' on Thursday and bumped up the price target to 1,950p from 1,160p following the company's "strong" first-half results a day earlier.
Read moreThursday broker round-up
16th Aug 2018 13:09
(Sharecast News) - Esure Group: UBS upgrades to neutral with a target price of 280p.
Read moreGenerics and injectables drive first half growth at Hikma Pharmaceuticals
15th Aug 2018 07:23
(Sharecast News) - Generic drugmaker Hikma Pharmaceuticals issued its interim results for the six months ended 30 June on Wednesday, reporting an 11% improvement in group revenue to $989m, or 10% in constant currency.
Read moreThursday broker round-up
9th Aug 2018 13:02
(Sharecast News) - BBA Aviation: Liberum upgrades to buy with a target price of 370p.
Read moreHikma signs Easyhaler deal with Orion
13th Feb 2017 09:23
(ShareCast News) - Hikma Pharmaceuticals has signed an exclusive licensing and distribution agreement with Finland's Orion for its new Easyhaler combination product for the treatment of asthma and chronic obstructive pulmonary disease. Under the terms of the agreement, Hikma has the exclusive rights
Read moreFTSE 100 movers: Rio Tinto zips higher as Reckitt Benckiser falls
10th Feb 2017 17:10
(ShareCast News) - FTSE 100 is higher on Friday afternoon thanks to a string of mining behemoths led by Rio Tinto congregating atop the risers' list, albeit offset by a motley group of fallers led by consumer goods giant Reckitt Benckiser. London's top tier index closed 0.40% higher to 7,258.75 poin
Read moreSector movers: Cyclicals bounce back, Evraz in the lead
1st Feb 2017 15:46
(ShareCast News) - There was a clear split in the market on Wednesday as cyclicals bounced back and the more defensive segments of the market were relegated to the bottom of the pile. Thus, shares in Prudential and Aviva were to be seen pacing gains among life insurers as yields on benchmark 10-year
Read more